RegeneRx Biopharmaceuticals (RGRX) Short Interest Ratio & Short Volume $0.07 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest RegeneRx Biopharmaceuticals Short Interest DataRegeneRx Biopharmaceuticals (RGRX) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 998 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.14Short Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,509,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume40 sharesAverage Trading Volume998 sharesToday's Volume Vs. Average4% Short Selling RegeneRx Biopharmaceuticals? Sign up to receive the latest short interest report for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGRX Short Interest Over TimeRGRX Days to Cover Over TimeRGRX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin RegeneRx Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024100 shares $0.14 No ChangeN/A0.3 $0.00 11/15/2024100 shares $0.14 No ChangeN/A1 $0.00 10/31/2024100 shares $0.14 No ChangeN/A0.1 $0.00 10/15/2024100 shares $0.14 No ChangeN/A0.1 $0.00 9/30/2024100 shares $0.14 No ChangeN/A1 $0.00 9/15/2024100 shares $0.14 No ChangeN/A0.1 $0.00 Get the Latest News and Ratings for RGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024100 shares $0.14 No ChangeN/A0.3 $0.00 8/15/2024100 shares $5.22 No ChangeN/A0.3 $0.05 7/31/2024100 shares $0.14 No ChangeN/A0.3 $0.00 7/15/2024100 shares $0.14 No ChangeN/A1 $0.00 6/30/2024100 shares $0.14 No ChangeN/A1 $0.00 6/15/2024100 shares $0.14 No ChangeN/A0 $0.00 5/31/2024100 shares $0.14 No ChangeN/A1 $0.00 5/15/2024100 shares $0.14 No ChangeN/A1 $0.00 4/30/2024100 shares $0.14 No ChangeN/A1 $0.00 4/15/2024100 shares $5.22 No ChangeN/A1 $0.05 3/31/2024100 shares $0.14 No ChangeN/A0.2 $0.00 3/15/2024100 shares $0.12 No ChangeN/A0.2 $0.00 2/29/2024100 shares $0.12 No ChangeN/A1 $0.00 2/15/2024100 shares $0.12 No ChangeN/A1 $0.00 1/15/2024100 shares $0.12 No ChangeN/A0.3 $0.00 12/31/2023100 shares $0.12 No ChangeN/A0 $0.00 12/15/2023100 shares $0.04 No ChangeN/A0.3 $0.00 11/30/2023100 shares $0.09 No ChangeN/A0.2 $0.00 10/15/2023600 shares $6.51 -92.9%N/A0 $0.01 9/30/20238,500 shares $144.50 -28.0%N/A0.1 $0.02 9/15/202311,800 shares $251.34 -39.2%N/A0.1 $0.02 8/31/202319,400 shares $310.40 -22.7%N/A0.1 $0.02 8/15/202325,100 shares $710.33 +13.6%N/A0.1 $0.03 7/31/202322,100 shares $559.13 +3,583.3%N/A0.1 $0.03 7/15/2023600 shares $21.90 -25.0%N/A0 $0.04 6/30/2023800 shares $21.28 -96.3%N/A0 $0.03 6/15/202321,500 shares $655.75 +2.9%N/A0.1 $0.03 5/31/202320,900 shares $833.91 +945.0%N/A0.1 $0.04 5/15/20232,000 shares $115.00 +11.1%N/A0 $0.06 4/30/20231,800 shares $126.00 -98.4%N/A0 $0.07 4/15/2023108,800 shares $3,264.00 +29.8%N/A0.1 $0.03 3/31/202383,800 shares $8,799.00 -0.2%N/A2 $0.11 3/15/202384,000 shares $9,979.20 -0.5%N/A5.4 $0.12 2/28/202384,400 shares $11,104.59 -0.2%N/A3.2 $0.13Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. 2/15/202384,600 shares $9,509.04 +0.7%N/A1.6 $0.11 1/31/202384,000 shares $12,591.60 +0.1%N/A2.5 $0.15 1/15/202383,900 shares $12,576.61 +0.1%N/A1.5 $0.15 12/30/202283,800 shares $11,639.82 -0.5%N/A1 $0.14 12/15/202284,200 shares $11,788.00 No ChangeN/A0.9 $0.14 11/30/202284,200 shares $13,472.00 +0.5%N/A3.4 $0.16 11/15/202283,800 shares $14,518.35 No ChangeN/A1.1 $0.17 10/31/202283,800 shares $14,246.00 -0.4%N/A1.5 $0.17 10/15/202284,100 shares $14,952.98 +0.4%N/A3.8 $0.18 9/30/202283,800 shares $11,732.00 No ChangeN/A3.1 $0.14 9/15/202283,800 shares $14,329.80 -1.2%N/A1.8 $0.17 8/31/202284,800 shares $13,652.80 +1.1%N/A1.7 $0.16 8/15/202283,900 shares $15,102.00 -18.4%N/A1.5 $0.18 7/31/2022102,800 shares $19,018.00 -5.6%N/A1.7 $0.19 7/15/2022108,900 shares $20,658.33 +7.2%N/A1.3 $0.19 6/30/2022101,600 shares $15,748.00 +12.3%N/A1.1 $0.16 6/15/202290,500 shares $14,027.50 -15.9%N/A4 $0.16 5/31/2022107,600 shares $19,368.00 +5.8%N/A1.5 $0.18 5/15/2022101,700 shares $19,323.00 +15.3%N/A1 $0.19 4/30/202288,200 shares $13,671.00 -1.1%N/A2 $0.16 4/15/202289,200 shares $15,940.04 -35.4%N/A0.8 $0.18 3/31/2022138,000 shares $24,840.00 +35.2%N/A1.2 $0.18 3/15/2022102,100 shares $21,185.75 -1.7%N/A0.7 $0.21 2/28/2022103,900 shares $27,014.00 +9.1%N/A0.4 $0.26 2/15/202295,200 shares $25,704.00 +561.1%N/A0.4 $0.27 1/31/202214,400 shares $3,924.00 -26.5%N/A0.1 $0.27 1/15/202219,600 shares $3,547.60 +71.9%N/A0.2 $0.18 12/31/202111,400 shares $1,824.00 -6.6%N/A0 $0.16 12/15/202112,200 shares $1,875.14 +14.0%N/A0 $0.15 11/30/202110,700 shares $2,138.93 -20.2%N/A0.1 $0.20 11/15/202113,400 shares $2,211.00 -2.9%N/A0.1 $0.17 10/29/202113,800 shares $2,482.62 +13.1%N/A0 $0.18 10/15/202112,200 shares $2,220.40 -56.6%N/A0.1 $0.18 9/30/202128,100 shares $4,636.50 -66.2%N/A0.1 $0.17 9/15/202183,100 shares $16,620.00 +6,292.3%N/A0.5 $0.20 8/31/20211,300 shares $284.70 -84.0%N/A0 $0.22 8/13/20218,100 shares $2,065.50 +636.4%N/A0.1 $0.26 7/30/20211,100 shares $294.25 -85.5%N/A0 $0.27 7/15/20217,600 shares $2,204.00 +442.9%N/A0.1 $0.29 6/30/20211,400 shares $379.40 -67.4%N/A0 $0.27 6/15/20214,300 shares $1,236.25 +43.3%N/A0 $0.29 5/28/20213,000 shares $907.47 -45.5%N/A0 $0.30 5/14/20215,500 shares $1,160.23 -66.3%N/A0.1 $0.21 4/30/202116,300 shares $3,586.00 +270.5%N/A0.1 $0.22 4/15/20214,400 shares $859.98 +91.3%N/A0 $0.20 3/31/20212,300 shares $632.39 -80.5%N/A0 $0.27 3/15/202111,800 shares $7,906.00 -37.9%N/A0.1 $0.67 2/26/202119,000 shares $13,775.00 +475.8%N/A0.1 $0.73 2/12/20213,300 shares $1,947.00 -88.3%N/A0 $0.59 1/29/202128,100 shares $13,038.40 +1,121.7%N/A0.1 $0.46Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. 1/15/202113,000 shares $6,370.00 +7.4%N/A0.1 $0.49 12/31/202026,400 shares $12,513.60 +103.1%N/A0.1 $0.47 12/15/202013,000 shares $6,577.35 +7.4%N/A0.1 $0.51 11/30/202012,100 shares $7,139.00 +348.2%N/A0.1 $0.59 11/15/20202,700 shares $1,458.00 -87.0%N/A0 $0.54 10/30/202020,800 shares $11,752.00 +116.7%N/A0.2 $0.57 10/15/20209,600 shares $4,310.40 +108.7%N/A0.1 $0.45 9/30/20204,600 shares $1,830.80 +283.3%N/A0 $0.40 9/15/20201,200 shares $715.20 -42.9%N/A0 $0.60 8/31/20202,100 shares $1,197.00 -12.5%N/A0 $0.57 8/14/20202,400 shares $1,608.00 -82.9%N/A0 $0.67 7/31/202014,000 shares $5,320.00 -52.5%N/A0.1 $0.38 7/15/202029,500 shares $11,505.00 +1,538.9%N/A0.2 $0.39 6/30/20201,800 shares $567.36 -64.0%N/A0 $0.32 6/15/20205,000 shares $1,450.50 -75.5%N/A0 $0.29 5/29/202020,400 shares $5,916.00 -2.4%N/A0.3 $0.29 5/15/202020,900 shares $4,932.40 +44.1%N/A0.3 $0.24 4/30/202014,500 shares $3,741.00 +866.7%N/A0.3 $0.26 4/15/20201,500 shares $444.00 +150.0%N/A0 $0.30 3/31/2020600 shares $162.00 -94.3%N/A0 $0.27 3/13/202010,500 shares $2,100.00 +228.1%N/A0.1 $0.20 2/28/20203,200 shares $800.00 -54.9%N/A0 $0.25 2/14/20207,100 shares $1,349.00 +208.7%N/A0 $0.19 1/31/20202,300 shares $598.00 -94.1%N/A0 $0.26 1/15/202038,700 shares $7,159.50 +6,350.0%N/A0.8 $0.19 12/31/2019600 shares $168.00 -94.1%N/A0 $0.28 RGRX Short Interest - Frequently Asked Questions What is RegeneRx Biopharmaceuticals' current short interest? Short interest is the volume of RegeneRx Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 100 shares of RGRX short. Learn More on RegeneRx Biopharmaceuticals' current short interest. How does RegeneRx Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to RegeneRx Biopharmaceuticals: Intellipharmaceutics International Inc. (0.00%), IMV Inc. (1.31%), eFFECTOR Therapeutics, Inc. (16.84%), Alvotech (0.08%), Basilea Pharmaceutica AG (0.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short RegeneRx Biopharmaceuticals stock? Short selling RGRX is an investing strategy that aims to generate trading profit from RegeneRx Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RegeneRx Biopharmaceuticals? A short squeeze for RegeneRx Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RGRX, which in turn drives the price of the stock up even further. How often is RegeneRx Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGRX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Intellipharmaceutics International Short Interest Sienna Biopharmaceuticals Short Interest eFFECTOR Therapeutics Short Interest 180 Life Sciences Short Interest 4Front Ventures Short Interest Agentix Short Interest Algernon Pharmaceuticals Short Interest Allstar Health Brands Short Interest Alvotech Short Interest Alvotech Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:RGRX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RegeneRx Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RegeneRx Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
